Lung cancer affects non-smokers, with 25% of patients having never smoked, highlighting the need for awareness of persistent symptoms and environmental risk factors. Genetic testing is essential for ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Almost five new cases of lung cancer are diagnosed every minute globally and one of them would be a non-smoker. Screening gap remains one of the critical challenges of lung cancer prevention as most ...

The estimated glomerular filtration rate (eGFR) is a blood test to assess kidney function. The formula for calculating eGFR takes the patient’s body size, age, and sex into account to predict how well ...

In a recent study published in the journal Nature Biotechnology, researchers in Switzerland used base and prime editing to create and analyze a wide array of variants of the epithelial growth factor ...

Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System certificate, making it the first Idylla Test to achieve Class C companion ...

Genetic testing can be a fearful, daunting, overwhelming, exciting, or joyful experience. In many cases, the emotions of people who pursue genetic testing can be described with more than just one of ...

Healthcare professionals can use genetic tests to identify genetic changes that people inherit from their parents through DNA. The results of genetic tests can inform diagnoses or provide information ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...